medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 23, 2024
Abstract
Individual
variability
in
clinical
response
to
dopaminergic
replacement
therapy
(DRT)
is
a
key
barrier
efficacious
treatment
for
patients
with
Parkinson’s
disease
(PD).
A
better
understanding
of
the
neurobiological
sources
such
inter-individual
differences
necessary
inform
future
interventions
and
motivate
translational
research.
One
potential
source
this
an
unintended
secondary
activation
extra-nigrostriatal
dopamine
systems
by
DRT,
particularly
neocortex.
In
study,
we
use
magnetoencephalography
data
collected
from
PD
before
after
DRT
map
their
individual
cortical
neurophysiological
responses
pharmacotherapy.
By
combining
these
maps
normative
atlases
receptor
transporter
densities,
link
variable
enhancement
rhythmic
beta
activity
dopamine-rich
regions.
Importantly,
who
exhibited
larger
showed
smaller
improvement
indicating
medication
PD.
We
conclude
that
findings
our
basis
often
seen
PD,
indicate
methodological
approach
may
be
useful
data-driven
contextualization
effects
on
neurophysiology
research
applications.
Journal of Neurology,
Год журнала:
2023,
Номер
270(11), С. 5313 - 5326
Опубликована: Авг. 2, 2023
Abstract
Parkinson’s
disease
(PD)
is
the
second
most
common
neurodegenerative
bearing
a
severe
social
and
economic
impact.
So
far,
there
no
known
modifying
therapy
current
available
treatments
are
symptom
oriented.
Deep
Brain
Stimulation
(DBS)
established
as
an
effective
treatment
for
PD,
however
systems
lag
behind
today’s
technological
potential.
Adaptive
DBS,
where
stimulation
parameters
depend
on
patient’s
physiological
state,
emerges
important
step
towards
“smart”
strategy
that
enables
adaptive
personalized
therapy.
This
new
facilitated
by
currently
neurotechnologies
allowing
simultaneous
monitoring
of
multiple
signals,
providing
relevant
information.
Advanced
computational
models
analytical
methods
tool
to
explore
richness
data
identify
signal
properties
close
loop
in
DBS.
To
tackle
this
challenge,
machine
learning
(ML)
applied
DBS
have
gained
popularity
due
their
ability
make
good
predictions
presence
variables
subtle
patterns.
ML
based
approaches
being
explored
at
different
fronts
such
identification
electrophysiological
biomarkers
development
control
systems,
leading
relief.
In
review,
we
how
can
help
overcome
challenges
closed-loop
particularly
its
role
search
electrophysiology
biomarkers.
Promising
results
demonstrate
potential
supporting
generation
with
better
management
delivery,
resulting
more
efficient
patient-tailored
treatments.
Progress in Neurobiology,
Год журнала:
2023,
Номер
231, С. 102538 - 102538
Опубликована: Окт. 11, 2023
Patients
with
Parkinson's
disease
(PD)
exhibit
multifaceted
changes
in
neurophysiological
brain
activity,
hypothesized
to
represent
a
global
cortical
slowing
effect.
Using
task-free
magnetoencephalography
and
extensive
clinical
assessments,
we
found
that
PD
is
differentially
associated
motor
non-motor
symptoms
along
sagittal
gradient
over
the
anatomy.
In
superior
parietal
regions,
reflects
an
adverse
effect
scales
cognitive
impairments,
while
across
inferior
frontal
cortex,
compatible
compensatory
role.
This
adverse-to-compensatory
sensitive
individual
profiles,
such
as
drug
regimens
laterality
of
symptoms;
it
also
aligned
topography
neurotransmitter
transporter
systems
relevant
PD.
We
conclude
patients
signals
both
deleterious
protective
mechanisms
disease,
from
posterior
anterior
regions
respectively,
functional
relevance
symptoms.
npj Parkinson s Disease,
Год журнала:
2025,
Номер
11(1)
Опубликована: Янв. 20, 2025
Abstract
Neuromodulation
therapy
comprises
a
range
of
non-destructive
and
adjustable
methods
for
modulating
neural
activity
using
electrical
stimulations,
chemical
agents,
or
mechanical
interventions.
Here,
we
discuss
how
electrophysiological
brain
recording
imaging
at
multiple
scales,
from
cells
to
large-scale
networks,
contribute
defining
the
target
location
stimulation
parameters
neuromodulation,
with
an
emphasis
on
deep
(DBS).
Frontiers in Neuroscience,
Год журнала:
2023,
Номер
16
Опубликована: Янв. 11, 2023
Subthalamic
deep
brain
stimulation
(DBS)
is
an
established
therapy
to
treat
Parkinson's
disease
(PD).
To
maximize
therapeutic
outcome,
optimal
DBS
settings
must
be
carefully
selected
for
each
patient.
Unfortunately,
this
not
always
achieved
because
of:
(1)
increased
technological
complexity
of
devices,
(2)
time
restraints,
or
lack
expertise,
and
(3)
delayed
response
some
symptoms.
Biomarkers
accurately
predict
the
most
effective
patient
could
streamline
process
improve
outcomes.To
investigate
use
evoked
potentials
(EPs)
clinical
outcomes
in
PD
patients
with
DBS.In
ten
(12
hemispheres),
a
monopolar
review
was
performed
by
systematically
stimulating
on
contact
measuring
window.
Standard
imaging
data
were
collected.
EEG-based
EPs
then
recorded
at
10
Hz
50
s
DBS-contact.
Linear
mixed
models
used
assess
how
well
both
image-derived
information
predicted
data.Evoked
potential
peaks
3
ms
(P3)
(P10)
observed
nine
eleven
hemispheres,
respectively.
Clinical
using
either
P3
P10.
A
separate
model
showed
that
also
similar
accuracy.
Combining
one
yielded
highest
predictive
value.Evoked
can
responses.
further
improves
prediction.
Future
refinement
approach
may
programming,
thereby
improving
outcomes.ClinicalTrials.gov,
identifier
NCT04658641.
npj Digital Medicine,
Год журнала:
2024,
Номер
7(1)
Опубликована: Окт. 2, 2024
Abstract
Improving
health-related
quality
of
life
(QoL)
is
crucial
for
managing
Parkinson’s
disease.
However,
QoL
outcomes
after
deep
brain
stimulation
(DBS)
the
subthalamic
nucleus
(STN)
vary
considerably.
Current
approaches
lack
integration
demographic,
patient-reported,
neuroimaging,
and
neurophysiological
data
to
understand
this
variability.
This
study
used
explainable
machine
learning
analyze
multimodal
factors
affecting
changes,
measured
by
Disease
Questionnaire
(PDQ-39)
in
63
patients,
quantified
each
variable’s
contribution.
Results
showed
that
preoperative
PDQ-39
scores
upper
beta
band
activity
(>20
Hz)
left
STN
were
key
predictors
changes.
Lower
initial
burden
predicted
worsening,
while
improvement
was
associated
with
higher
activity.
Additionally,
electrode
positions
along
superior-inferior
axis,
especially
relative
z
=
−7
coordinate
standard
space,
influenced
outcomes,
improved
worsened
above
below
marker.
emphasizes
a
tailored,
data-informed
approach
optimize
DBS
treatment
improve
patient
QoL.
Frontiers in Human Neuroscience,
Год журнала:
2022,
Номер
16
Опубликована: Сен. 8, 2022
Background
The
therapeutic
effect
of
deep
brain
stimulation
(DBS)
the
subthalamic
nucleus
(STN)
for
Parkinson's
disease
(PD)
is
related
to
modulation
pathological
neural
activities,
particularly
synchronization
in
β
band
(13–35
Hz).
However,
whether
local
activity
STN
region
can
directly
predict
outcome
remains
unclear.
Objective
We
tested
hypothesis
that
low-
(13–20
Hz)
and/or
high-
(20–35
activities
recorded
from
DBS
efficacy.
Methods
Local
field
potentials
(LFPs)
were
26
patients
undergoing
surgery
area.
Recordings
made
after
implantation
electrode
prior
its
connection
a
stimulator.
maximum
normalized
powers
theta
(4–7
Hz),
alpha
(7–13
and
low-γ
(40–55
subbands
postoperatively
LFP
correlated
with
stimulation-induced
improvement
contralateral
tremor
or
bradykinesia–rigidity.
distance
between
contact
selected
subband
power
was
Following
identification
potential
predictors
by
significant
correlations,
multiple
regression
analysis
performed
evaluate
their
on
outcome.
Results
positively
bradykinesia–rigidity
(
r
s
=
0.549,
p
<
0.0001).
negatively
−0.452,
0.001).
No
correlation
observed
power.
both
analysis,
explaining
37.4%
variance
altogether.
Tremor
not
significantly
any
frequency.
Conclusion
High-
oscillations,
but
lead
inform
PD.
oscillations
help
refine
targeting
selection
therapy.
CNS Neuroscience & Therapeutics,
Год журнала:
2023,
Номер
29(10), С. 2998 - 3013
Опубликована: Апрель 30, 2023
Parkinson's
disease
(PD)
is
a
pervasive
neurodegenerative
disease,
and
levodopa
(L-dopa)
its
preferred
treatment.
The
pathophysiological
mechanism
of
levodopa-induced
dyskinesia
(LID),
the
most
common
complication
long-term
L-dopa
administration,
remains
obscure.
Accumulated
evidence
suggests
that
dopaminergic
as
well
non-dopaminergic
systems
contribute
to
LID
development.
As
5-hydroxytryptamine
1A/1B
receptor
agonist,
eltoprazine
ameliorates
dyskinesia,
although
little
known
about
electrophysiological
mechanism.
aim
this
study
was
investigate
cumulative
effects
chronic
administration
potential
eltoprazine's
amelioration
at
level
in
rats.Neural
analysis
techniques
were
conducted
on
acquired
local
field
(LFP)
data
from
primary
motor
cortex
(M1)
dorsolateral
striatum
(DLS)
during
different
pathological
states
obtain
information
power
spectrum
density,
theta-gamma
phase-amplitude
coupling
(PAC),
functional
connectivity.
Behavior
tests
AIMs
scoring
performed
verify
PD
model
establishment
evaluate
severity.We
detected
exaggerated
gamma
activities
dyskinetic
state,
with
features
impacts
distinct
regions.
Gamma
oscillations
M1
narrowband
manner,
whereas
DLS
had
broadband
appearance.
Striatal
PAC
state
contributed
oscillation,
aperiodic-corrected
cortical
beta
correlated
robustly
M1.
M1-DLS
coherence
phase-locking
values
(PLVs)
band
enhanced
following
administration.
Eltoprazine
intervention
reduced
oscillations,
DLS,
PLVs
alleviate
dyskinesia.Excessive
oscillation
compelling
clinical
indicator
dyskinesia.
detection
connectivity
gamma-band
can
be
used
guide
optimize
deep
brain
stimulation
parameters.
has
application
for